Eli Lilly Sued Over Mounjaro Stomach Paralysis Risk
A 44-year-old woman from Louisiana has filed a lawsuit against the manufacturers of Mounjaro and Ozempic, another similar diabetes medication, alleging that the companies failed to adequately warn patients about the risk of severe gastrointestinal problems associated with the drugs.
The lawsuit claims that Eli Lilly and Novo Nordisk, the respective manufacturers of Mounjaro and Ozempic, “downplayed the severity of the gastrointestinal events” caused by their medications, which include gastroparesis, stomach paralysis, gastroenteritis, and stomach inflammation.
According to the lawsuit, Plaintiff Jaclyn Bjorklund was prescribed Ozempic for over 1 year before switching to Mounjaro in July and suffered from “severe gastrointestinal events,” including severe vomiting, stomach pain, gastrointestinal burning, multiple hospitalizations and the loss of teeth from excessive vomiting.
While the labeling for both Mounjaro and Ozempic warns that the medications delay gastric emptying and can cause a variety of stomach problems, they do not warn about the risk of gastroparesis.
Bjorklund is accusing Novo and Lilly of knowing about the risk of severe gastrointestinal problems with weight loss drugs like Mounjaro and Ozempic, yet failing to disclose this risk to patients.
As a result, the suit claimed that Bjorklund “was and still is caused to suffer from severe gastrointestinal issues, as well as other severe and personal injuries which are permanent and lasting in nature, physical pain, and mental anguish.”
What is Mounjaro?
Mounjaro (tripeptide) is a prescription medication used to treat type 2 diabetes. The drug is administered through subcutaneous injection (under the skin). Mounjaro is manufactured and marketed by Eli Lilly and was approved by the U.S. Food and Drug Administration (FDA) in May 2022.
How Does it Work?
Mounjaro works by increasing insulin production when the patient's blood sugar is rising. The drug also decreases the liver's production of sugar.
Is Mounjaro Approved to Treat Weight Loss?
Mounjaro is currently only approved as a treatment for type 2 diabetes. However, the drug is often prescribed "off-label" to treat obesity. In 2022, the FDA granted Mounjaro a “fast-track” designation for review to treat obesity in overweight individuals.
What is Stomach Paralysis?
Paralysis of the stomach, or gastroparesis, occurs when the stomach is unable to empty food normally. In most people, the muscles of the digestive tract use contractions to move the food along; however, in patients with gastroparesis, damaged muscles and nerves that control the movement don’t function correctly. Stomach paralysis is common in patients who have had type 2 diabetes for a long time, but the condition can also occur in non-diabetic individuals.
- Abdominal bloating
- Abdominal pain
- A feeling of fullness after eating just a few bites
- Vomiting undigested food eaten a few hours earlier
- Acid reflux
- Changes in blood sugar levels
- Lack of appetite
- Weight loss/malnutrition
Mounjaro Maker Sued Over "Stomach Paralysis" Claims: NBC News Video
Other Mounjaro Side Effects
Common side effects of Mounjaro include:
- Decreased appetite
- Upper abdominal discomfort
- Abdominal pain
- Trulicity Stomach Paralysis Lawsuit
- Weight Loss Drug Stomach Paralysis Attorney
- Wegovy Stomach Paralysis Litigation
See all related dangerous drug lawsuits our attorneys covered so far.
Get a Free Mounjaro Stomach Paralysis Lawsuit Evaluation With Our Lawyers
The Pharmaceutical Litigation Group at Schmidt & Clark, LLP law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Mounjaro Stomach Paralysis Lawsuits. We are handling individual litigation nationwide and currently accepting lawsuits in all 50 states.
Again, if you or a loved one suffered from stomach paralysis or another injury after taking Mounjaro or another weight loss medication, you should contact our law firm immediately. Consumers may be entitled to a settlement by filing a lawsuit, and our lawyers can help you receive fair compensation.